RSMV - ETF AI Analysis
Top Page
Relative Strength Managed Volatility Strategy ETF 1Shs (RSMV)
Rating:60Neutral
Price Target:―
Positive Factors
Solid Year-to-Date Performance
The ETF has delivered positive returns so far this year, showing that its strategy has recently been working for investors.
High-Quality Defensive Holdings
Several top positions are large, well-known health care and consumer companies that have shown strong or steady performance, which can help stabilize the fund.
Sector Diversification Across Key Industries
Exposure to financials, technology, health care, consumer defensive, energy, and other sectors helps spread risk across different parts of the economy.
Negative Factors
High Expense Ratio
The fund charges relatively high annual fees, which can eat into long-term returns compared with lower-cost ETFs.
Concentration in a Few Large Positions
One holding is very large and several others are sizable, meaning the fund’s performance is heavily influenced by a small group of stocks.
U.S.-Heavy Geographic Exposure
With most assets invested in U.S. companies, the ETF offers limited diversification across global markets.
RSMV vs. SPDR S&P 500 ETF (SPY)
AUMN/A
RegionNorth America
Expense Ratio0.95%
Beta0.65
IssuerTeucrium
Inception DateJan 13, 2025
Dividend Yield0.95%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume2,671
30 Day Avg. Volume4,853
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
32.49Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering29
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
RSMV Summary
RSMV is an actively managed ETF that follows a “managed volatility” growth theme across the total U.S. stock market, rather than tracking a single index. It looks for companies showing strong recent performance while trying to smooth out big ups and downs. The fund holds many well-known names such as Merck, Eli Lilly, Coca-Cola, IBM, and Johnson & Johnson, and spreads investments across sectors like financials, technology, and health care. Someone might consider RSMV for long-term growth with some built-in risk control, but it can still go up and down with the stock market and charges a relatively high fee.
How much will it cost me?The Relative Strength Managed Volatility Strategy ETF (RSMV) has an expense ratio of 0.95%, which means you’ll pay $9.50 per year for every $1,000 invested. This is higher than average because it’s actively managed, meaning the fund managers are making strategic decisions to optimize growth and manage risk rather than simply tracking a market index.
What would affect this ETF?The RSMV ETF, with strong exposure to sectors like Technology and Health Care, could benefit from continued innovation and consumer demand in these areas, as well as a stable U.S. economy. However, it may face challenges if interest rates rise, potentially impacting growth-focused companies, or if regulatory changes affect key holdings like Apple and Adobe. Additionally, market volatility could influence performance despite the fund's managed volatility strategy.
RSMV Top 10 Holdings
RSMV is leaning heavily into U.S. health care and defensive blue chips, with names like Merck, Eli Lilly, Thermo Fisher, AbbVie, and Johnson & Johnson doing most of the heavy lifting as their shares have been steadily rising. Coca-Cola adds another steady, defensive engine that’s been quietly pushing the fund forward. On the flip side, Home Depot looks a bit tired and IBM has been lagging this year, acting more like a brake than an accelerator. Overall, the ETF is U.S.-centric, with a clear tilt toward stable, growth-oriented health care leaders.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ― | 12.92% | $2.60M | ― | ― | ― | |
| ― | 5.01% | $1.01M | ― | ― | ― | |
| Merck & Company | 3.34% | $673.08K | $366.00B | 76.36% | 80 Outperform | |
| Thermo Fisher | 3.25% | $653.41K | $230.05B | 26.27% | 72 Outperform | |
| Microsoft | 3.18% | $639.41K | $3.81T | 1.35% | 79 Outperform | |
| Visa | 3.15% | $633.65K | $712.47B | 8.48% | 70 Outperform | |
| Arista Networks | 3.14% | $632.43K | $246.42B | 43.08% | 83 Outperform | |
| Mastercard | 3.12% | $627.23K | $521.49B | 0.00% | 75 Outperform | |
| Palo Alto Networks | 3.11% | $625.96K | $302.85B | 95.04% | 73 Outperform | |
| International Business Machines | 3.10% | $624.20K | $221.96B | -3.24% | 79 Outperform |
RSMV Technical Analysis
Positive
―
Price Trends
29.05
Negative
28.83
Positive
28.03
Positive
Market Momentum
-0.02
Positive
49.20
Neutral
27.96
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For RSMV, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 29.09, equal to the 50-day MA of 29.05, and equal to the 200-day MA of 28.03, indicating a neutral trend. The MACD of -0.02 indicates Positive momentum. The RSI at 49.20 is Neutral, neither overbought nor oversold. The STOCH value of 27.96 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for RSMV.
RSMV Peer Comparison
Comparison Results
Performance Comparison
RSMV
Relative Strength Managed Volatility Strategy ETF 1Shs
28.98
3.34
13.03%
CGGR
Capital Group Growth ETF
―
―
―
WINN
Harbor Long-Term Growers ETF
―
―
―
LSGR
Natixis Loomis Sayles Focused Growth ETF
―
―
―
GQGU
GQG US Equity ETF
―
―
―
BASG
Brown Advisory Sustainable Growth ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents